# Study of the Capacity of the MRI Spectroscopy to Define the Tumor Area Enriched in Glioblastoma Stem Cells. Proof of Concept Study

> **NCT01872221** · NA · COMPLETED · sponsor: **Institut Claudius Regaud** · enrollment: 21 (actual)

## Conditions studied

- Glioblastoma

## Interventions

- **PROCEDURE:** Surgery (based on preoperative multimodal MRI) followed by the standard radio-chemotherapy stupp protocol

## Key facts

- **NCT ID:** NCT01872221
- **Lead sponsor:** Institut Claudius Regaud
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-05
- **Primary completion:** 2018-04
- **Final completion:** 2018-04
- **Target enrollment:** 21 (ACTUAL)
- **Last updated:** 2026-04-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01872221

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01872221, "Study of the Capacity of the MRI Spectroscopy to Define the Tumor Area Enriched in Glioblastoma Stem Cells. Proof of Concept Study". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT01872221. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*